...
首页> 外文期刊>International Journal of Pharmacy and Pharmaceutical Sciences >EFFICACY OF UNANI FORMULATIONS IN CHRONIC ENDOCERVICITIS: A RANDOMIZED COMPARATIVE STUDY
【24h】

EFFICACY OF UNANI FORMULATIONS IN CHRONIC ENDOCERVICITIS: A RANDOMIZED COMPARATIVE STUDY

机译:乌纳尼配方在慢性内膜炎中的功效:随机比较研究

获取原文
           

摘要

Objective: To compare the efficacy of Unani formulation in chronic endocervicitis. Methods: A parallel, comparative randomized trial was conducted at Govt. Nizamia General Hospital, Hyderabad from 1998 to 2000 in 50 patients (25 in each group) with sign and symptoms of endocervicitis. The intervention was administered per oral and locally for 10 d from day 7 to day 16 of each menstrual cycle up to three consecutive months in both groups (A and B). Group A received 10 g powder of mako khusk, chobchini, and gul surkh with equal quantity of sugar orally, twice daily and locally douching with 100 ml of joshandae of barge neem (5g), and gule tesu (5g) was done per vaginum followed by insertion of humool (pessary) of loabe khatmi (5g), and safoof sadberg (3) mixed with roghan neem (10 ml). Group B received 7.5 g powder of ushba and kasni mixed with equal quantity of sugar orally, twice daily. Humool of loabe hulba (5g), and raswat (3g) with roghane gul was kept per vaginum. The outcome was inter-group comparison of effectiveness of Unani medicine by observing change in subjective and objective parameters of endocervicitis. Chi-square/Fisher Exact tests were carried out to observe the inter group comparison. Results: The demographic characteristics were statistically not significant (P>0.05) between the groups. No statistical difference was noted in the subjective and objective parameters of endocervicitis (P>0.05), showing that both groups were comparable. Conclusion: Group A and B were comparable in ameliorating sign and symptoms of endocervicitis because of anti-inflammatory, analgesic and anti-microbial effects. Further, randomized controlled trials are recommended. Keywords: Abnormal vaginal discharge, Endocervicitis, Randomized trial, Unani formulation.
机译:目的:比较Unani制剂在慢性宫颈癌中的疗效。方法:在Govt进行了一项平行的比较随机试验。 1998年至2000年,海得拉巴Nizamia总医院收治了50例宫颈癌的体征和症状的患者(每组25例)。在每个月经周期的第7天至第16天,两组(A和B)连续三个月通过口服和局部进行干预,持续10 d。 A组口服10克粉末的mako khusk,chobchini和gul surkh,并口服等量的糖,每天两次,并在局部用100 ml ge树印度jo(5 g)的杜鹃花(joshandae)进行灌洗,然后每次阴道进行一次gule tesu(5 g)。通过插入loabe khatmi(5 g)的哈莫尔(子宫托)和safoof sadberg(3)与roghan neem(10 ml)混合而成。 B组每天口服两次,将7.5 g ushba和kasni粉末与等量的糖混合。每个阴道保留loabe hulba(5g)和raswat(3g)与roghane gul的小菜。结果是通过观察宫颈内膜炎主观和客观参数的变化,对Unani药物的有效性进行了组间比较。卡方检验/ Fisher精确检验用于观察组间比较。结果:两组间的人口统计学特征无统计学意义(P> 0.05)。宫颈内膜炎的主观和客观参数无统计学差异(P> 0.05),表明两组具有可比性。结论:由于消炎,镇痛和抗菌作用,A组和B组在改善宫颈内膜炎的体征和症状方面具有可比性。此外,建议进行随机对照试验。关键字:白带异常,宫颈炎,随机试验,Unani配方。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号